Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Clinical and molecular determinants of response to maintenance olaparib for primary and recurrent epithelial ovarian carcinoma.
Matthew K Wagar, Kharmen Bharucha, Lauren Montemorano, Laura B Huffman, Amy L Godecker, Lisa M Barroilhet
Published: 202510.1007/s12094-025-04105-7
Abstract
PURPOSE: To characterize long-term (LT) and short-term (ST) responders to the Poly (ADP-ribose) polymerase inhibitor olaparib in the primary and recurrent maintenance setting. METHODS: Clinical and molecular data was collected for patients receiving…
Preview only. Read the full abstract at the source